Follow-up data of rituximab as adjuvant therapy in pemphigus

Follow-up data of rituximab as adjuvant therapy in pemphigus

Bibliographic Details
Main Authors:	Uday S Khopkar, Akansha Anil Chadha, M S N. Nitya, Vikram Lahoria
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Indian Journal of Dermatology
Online Access:	http://www.e-ijd.org/article.asp?issn=0019-5154;year=2017;volume=62;issue=6;spage=563;epage=565;aulast=Khopkar

Similar Items

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
by: Ashwin Agarwal, et al.
Published: (2018-01-01)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
by: Kanokrungsee S, et al.
Published: (2021-04-01)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021-10-01)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
by: Mohamad Y. Khatib, et al.
Published: (2021-02-01)

Rituximab: A Magic Bullet for Pemphigus
by: V. Anandan, et al.
Published: (2017-04-01)

Quantitative estimation of antidesmoglein autoantibodies by ELISA in pemphigus patients and its correlation with disease activity
by: Seema A Korgaonkar, et al.
Published: (2021-01-01)

Rituximab in pemphigus: Road covered and challenges ahead
by: Keshavamurthy Vinay, et al.
Published: (2018-01-01)

Four cases of recalcitrant pemphigus vulgaris salvaged with rituximab
by: Samyak Ganjre, et al.
Published: (2017-01-01)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
by: Sharon Baum, et al.
Published: (2020-10-01)

Extragenital lichen sclerosus et atrophicus co-exististing with pemphigus vulgaris
by: Chirag Desai, et al.
Published: (2017-01-01)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
by: Dae San Yoo, MD, et al.
Published: (2020-02-01)

A modified regimen of rituximab in pemphigus: A retrospective study
by: Tanvi Pradeep Vaidya, et al.
Published: (2020-01-01)

Delayed-onset serum sickness due to rituximab in pemphigus vulgaris
by: Ajay Deshpande
Published: (2019-01-01)

Rituximab therapy in pemphigus and other autoantibody-mediated diseases [version 1; referees: 3 approved]
by: Nina A. Ran, et al.
Published: (2017-01-01)

Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites
by: Kiran K Chotaliya, et al.
Published: (2015-01-01)

Rituximab for the treatment of pemphigus and pemphigoid: A case series of ten patients
by: Safaa S Alwaash, et al.
Published: (2019-01-01)

Clinical outcomes in patients with pemphigus vulgaris receiving a combination rituximab and intravenous immunoglobin therapy protocol
by: Zakka, Labib
Published: (2015)

Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy
by: Yung-Tsu Cho, et al.
Published: (2020-01-01)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
by: Sepideh Ashrafzadeh, BS, et al.
Published: (2020-08-01)

Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
by: Hoorieh Alaeen, MD, et al.
Published: (2019-12-01)

Pulse therapy in pemphigus: Ready reckoner
by: Anil Abraham, et al.
Published: (2016-01-01)

A comparative analysis of tuberculosis in vitro screening in pemphigus patients selected for treatment with rituximab
by: Magdalena Jałowska, et al.
Published: (2021-09-01)

Comparative retrospective evaluation of efficacy of rituximab therapy with dexamethasone cyclophosphamide pulse therapy in patients of pemphigus vulgaris at a tertiary care hospital
by: Preema Sinha, et al.
Published: (2020-01-01)

An Investigation on Micro-Raman Spectra and Wavelet Data Analysis for Pemphigus Vulgaris Follow-up Monitoring.
by: Maria Lepore, et al.
Published: (2008-06-01)

Granulomatous variant of giant centrifugal miliaria profunda in a hypothyroid infant: A case report
by: Akansha A Chadha, et al.
Published: (2019-01-01)

Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: A possible adverse effect of rituximab?
by: Kuan-Jou Wu, et al.
Published: (2021-01-01)

Management of pemphigus vulgaris with rituximab: A case report and brief review on emerging treatment options
by: Massillamani Francis, et al.
Published: (2019-01-01)

Treatment of post kala-azar dermal leishmaniasis with fungisome – A novel Indian liposomal amphotericin B
by: Akansha Anil Chadha, et al.
Published: (2020-01-01)

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP
by: M. E. Tsanyan, et al.
Published: (2014-06-01)

A Case of Chronic Conjunctivitis following Rituximab Therapy
by: Marnelli A. Bautista, et al.
Published: (2009-01-01)

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option
by: Franziska Schauer, et al.
Published: (2020-01-01)

Pemphigus Foliaceus—Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report
by: Magdalena Kraft, et al.
Published: (2018-11-01)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
by: Ralf Müller, et al.
Published: (2010-01-01)

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
by: Vivien Hébert, et al.
Published: (2021-05-01)

Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study
by: Khalaf Kridin, et al.
Published: (2021-09-01)

Rituximab Treatment for Paraneoplastic Pemphigus Associated with Follicular B-Cell Lymphoma: A Case Report and Review of Treatment Outcome
by: Waranaree Winayanuwattikun, M.D., et al.
Published: (2018-11-01)

A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021-01-01)

Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab
by: Jo Linda Sinagra, et al.
Published: (2021-04-01)

Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
by: Sravya M Bhatia, et al.
Published: (2020-01-01)

Rituximab Treatment for Paraneoplastic Pemphigus Associated with Follicular B-Cell Lymphoma: A Case Report and Review of Treatment Outcome
by: Waranaree Winayanuwattikun, et al.
Published: (2018-12-01)